1753-0407.13252 (explore) | nanodash

Login with ORCID

1753-0407.13252

Full identifier: https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13252

Assigned to 3 classes:

References

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
https://w3id.org/np/RA8MF1g4qF... RA8MF1g4qF	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://schema.org/ScholarlyArticle ScholarlyArticle	(unknown)	2025-07-18T12:44:22.271Z
https://w3id.org/np/RA8MF1g4qF... RA8MF1g4qF	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/name name	Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes	(unknown)	2025-07-18T12:44:22.271Z
https://w3id.org/np/RA8MF1g4qF... RA8MF1g4qF	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/description description	Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022 Apr;14(4):247-260. doi: 10.1111/1753-0407.13252.	(unknown)	2025-07-18T12:44:22.271Z
https://w3id.org/np/RA6TVqiMTt... RA6TVqiMTt	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://schema.org/ScholarlyArticle ScholarlyArticle	(unknown)	2025-07-18T12:08:56.193Z
https://w3id.org/np/RA6TVqiMTt... RA6TVqiMTt	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/name name	Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes	(unknown)	2025-07-18T12:08:56.193Z
https://w3id.org/np/RA6TVqiMTt... RA6TVqiMTt	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/description description	Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022 Apr;14(4):247-260. doi: 10.1111/1753-0407.13252.	(unknown)	2025-07-18T12:08:56.193Z
https://w3id.org/np/RAPibhKiAP... RAPibhKiAP	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://schema.org/ScholarlyArticle ScholarlyArticle	(unknown)	2025-07-18T12:07:36.837Z
https://w3id.org/np/RAPibhKiAP... RAPibhKiAP	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/name name	Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes	(unknown)	2025-07-18T12:07:36.837Z
https://w3id.org/np/RAPibhKiAP... RAPibhKiAP	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/description description	Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022 Apr;14(4):247-260. doi: 10.1111/1753-0407.13252.	(unknown)	2025-07-18T12:07:36.837Z
https://w3id.org/np/RAPibhKiAP... RAPibhKiAP	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	1753-0407.13252	http://schema.org/identifier identifier	1753-0407.13252	(unknown)	2025-07-18T12:07:36.837Z